MiMedx Group Stock (NASDAQ:MDXG), Quotes and News Summary

Q: What sector and industry does MiMedx Group (MDXG) operate in?

MiMedx Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MiMedx Group Stock (NASDAQ: MDXG) stock price, news, charts, stock research, profile.

Open	$7.410
Close	$7.130
Volume / Avg.	581.620K / 867.617K
Day Range	7.085 - 7.425
52 Wk Range	4.475 - 9.270
Market Cap	$1.052B
P/E Ratio	14.173
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	4.37%
Days to Cover	5.85

Recent News

Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.

Avi Kapoor

Chipotle, Amazon, Deckers Outdoor, Capital One And Other Stocks Move Higher On Friday

U.S. stocks traded mixed, with the Nasdaq Composite gaining more than 100 points on Friday. Here are some big stocks recording gains in today’s session.

Lisa Levin

MiMedx Targets Profitability with Strategic Realignment, Suspends Knee Osteoarthritis Program Activities

MiMedx Group Inc (NASDAQ: MDXG) announced a strategic realignment to focus its resources on its Wound & Surgical business, driving profitability and

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy MiMedx Group (MDXG) stock?

You can purchase shares of MiMedx Group (NASDAQ: MDXG) through any online brokerage.

View our list of the best stock brokerages.

Who are MiMedx Group's (MDXG) competitors?

Other companies in MiMedx Group’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE) and 4D Molecular Therapeutics (NASDAQ:FDMT).

What is the target price for MiMedx Group (MDXG) stock?

The latest price target for MiMedx Group (NASDAQ: MDXG) was reported by HC Wainwright & Co. on Wednesday, May 1, 2024. The analyst firm set a price target for 11.00 expecting MDXG to rise to within 12 months (a possible 54.28% upside). 8 analyst firms have reported ratings in the last year.

Current Stock Price for MiMedx Group (MDXG)?

The stock price for MiMedx Group (NASDAQ: MDXG) is $7.13 last updated May 6, 2024 at 4:00 PM EDT.

Does MiMedx Group (MDXG) pay a dividend?

There are no upcoming dividends for MiMedx Group.

When is MiMedx Group (NASDAQ:MDXG) reporting earnings?

MiMedx Group’s Q2 earnings are confirmed for Tuesday, July 30, 2024.

Is MiMedx Group (MDXG) going to split?

There is no upcoming split for MiMedx Group.

What sector and industry does MiMedx Group (MDXG) operate in?

MiMedx Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-